The global whole exome sequencing (WES) market is experiencing rapid expansion, driven by technological advancements in genomics, the falling cost of sequencing, and increasing adoption of precision medicine. According to Kings Research, the market was valued at USD 2,143.6 million in 2023 and is projected to grow from USD 2,563.2 million in 2024 to USD...